• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Asthma of Obesity: Investigator Explains the Phenotypes



Asthma of obesity affects more than 10% of men and 14% of women with obesity. Our interview with researcher Anne Dixon, MD, sheds light on this poorly appreciated asthma phenotype.

The connection between asthma and obesity is a complex one, according to pulmonologist and critical care medicine specialist Anne Dixon, MD. It is also not fully understood, even among asthma specialists.

Asthma of obesity affects approximately 1 in 10 men with obesity (11%) and nearly 14% of women with obesity and for a variety of reasons presents a significant treatment challenge.

Anne Dixon, MD, is a leading researcher in the complex area of asthma phenotypes and obesity and metabolism. She is professor of medicine at the Robert Larner School of Medicine at the University of Vermont, director of Pulmonary and Critical Care Medicine and director of the Vermont Lung Center. Patient Care recently asked her to talk about these overlapping diseases and particularly as they affect the primary care practitioner.

Anne Dixon, MD, is Professor of Medicine, Director, Pulmonary and Critical Care Medicine, Robert Larner School of Medicine, University of Vermont, Director, Vermont Lung Center

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
Related Content
© 2024 MJH Life Sciences

All rights reserved.